- Presentations
- 2
- Markets
- 1
Augtyro is a brand of Repotrectinib marketed by ER Squibb & Sons, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Repotrectinib
- Brand owner
- ER Squibb & Sons
- Registered in
- United States
- Strengths and forms
- 160 mg capsule, 40 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Augtyro 160 mg capsuleOral | ER Squibb & Sons | US FDA | Available on request |
| Augtyro 40 mg capsuleOral | ER Squibb & Sons | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Augtyro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.